0000950103-25-008512.txt : 20250806 0000950103-25-008512.hdr.sgml : 20250806 20250707161919 ACCESSION NUMBER: 0000950103-25-008512 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20250707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADC Therapeutics SA CENTRAL INDEX KEY: 0001771910 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: BIOPOLE STREET 2: ROUTE DE LA CORNICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 BUSINESS PHONE: 41 21 653 02 00 MAIL ADDRESS: STREET 1: BIOPOLE STREET 2: ROUTE DE LA CORNICHE 3B CITY: EPALINGES STATE: V8 ZIP: 1066 CORRESP 1 filename1.htm

 

 

 

 

July 7, 2025

 

VIA EDGAR

 

Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549

 

Re: ADC Therapeutics SA
Registration Statement on Form S-3
Registration No. 333-288437

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-288437) (the “Registration Statement”) of ADC Therapeutics SA. We respectfully request that the Registration Statement be declared effective as of 4:00 p.m., Eastern time, on July 9, 2025, or as soon as practicable thereafter.

 

Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Davis Polk & Wardwell LLP, by calling David Li at (212) 450-3861.

 

Thank you for your assistance in this matter.

 

Sincerely,

 

ADC Therapeutics SA

 
   
By: /s/ Peter J. Graham  
  Name: Peter J. Graham  
  Title: Chief Legal Officer  

 

 

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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